Drug Safety Monitoring—International Information

Drug Safety Monitoring—International Information

Experts of the Department for Evaluation of Medicinal Products’ Safety of the Scientific Centre for Expert Evaluation of Medicinal Products analysed administrative decisions of foreign regulatory authorities on limiting the use of some medicinal products and/or the need to introduce changes in patie...

Full description

Bibliographic Details
Main Authors:	E. V. Shubnikova, T. M. Bukatina, G. V. Kutekhova
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation 2020-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	adverse reactions postmarketing studies safety profile drugs patient information leaflet pharmacovigilance
Online Access:	https://www.risksafety.ru/jour/article/view/204

Similar Items

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Monitoring of Foreign Drug Safety Information
by: Editorial article
Published: (2019-12-01)

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities
by: Elena V. Shubnikova, et al.
Published: (2020-03-01)

From Monitoring Drug Safety to Monitoring Patient Safety: A Strategic Focus for the Activity of Pharmacists
by: Francisco Batel Marques
Published: (2017-10-01)

Drug Safety Monitoring Information
by: Elena V. Shubnikova, et al.
Published: (2020-06-01)

Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Drug interaction surveillance using individual case safety reports
by: Strandell, Johanna
Published: (2011)

Comparison of rates of nausea side effects for prescription medications from an online patient community versus medication labels: an exploratory analysis
by: David A. Blaser, et al.
Published: (2017-11-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital
by: Fabiana Rossi Varallo, et al.
Published: (2014-03-01)

Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital
by: Jair Antonio Ruiz-Garzon, et al.
Published: (2019-01-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)

Analysis of Administrative Decisions of Foreign Regulatory Authorities
by: Information relevant
Published: (2019-09-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Development of instrument to report and assess causality of adverse events related to herbal medicines
by: Patrícia de Carvalho Mastroianni, et al.

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

Knowledge, attitudes and practices of nurses and pharmacists towards adverse drug reaction reporting in the South African private hospital sector
by: Sophia Bogolubova, et al.
Published: (2018-11-01)

Pharmacovigilance: Boon for the safety and efficacy of ayuvedic formulations
by: Anand Chaudhary, et al.
Published: (2010-01-01)

Drug safety surveillance /Adverse drug reaction monitoring and establishing Pharmacovigilance Centres in teaching hospitals – A perspective
by: Shobha V. Huilgol
Published: (2016-07-01)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018-09-01)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
by: Pramod Kumar, et al.
Published: (2017-01-01)

Safety of Medication in Paediatrics
by: Star, Kristina
Published: (2013)

Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices
by: Mohit Hans, et al.
Published: (2018-01-01)

Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India
by: Anand Harugeri, et al.
Published: (2017-01-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
by: Josipa Bukic, et al.
Published: (2019-10-01)

Comparative Safety Profiles of Sedatives Commonly Used in Clinical Practice: A 10-Year Nationwide Pharmacovigilance Study in Korea
by: Yeo-Jin Choi, et al.
Published: (2021-08-01)

Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia
by: Ibrahim Sales, et al.
Published: (2017-09-01)

A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies
by: Anil Pacaci, et al.
Published: (2018-04-01)

Role of hospital pharmacists in reporting adverse drug reactions – A review
by: Sharmila P Nirojini, et al.
Published: (2012-01-01)

SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?
by: A. S. Kolbin, et al.
Published: (2013-05-01)

An evaluation of trigger tool method for adverse drug reaction monitoring at a tertiary care teaching hospital
by: Urmila Menat, et al.
Published: (2021-01-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)